COMPLETED

Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

NCT02188095•Aesculap AG

View on ClinicalTrials.gov

Summary

Clinical and radiological 10 year results of Excia T® Hip Stem

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient gave written informed consent
•age ≥ 18 years

Exclusion Criteria

•pregnancy

Locations (2)

Vulpius Klinik

Bad Rappenau, Germany

Diakonie Klinikum Stuttgart

Stuttgart, Germany

Key Dates

Start Date

September 3, 2014

Primary Completion Date

October 6, 2015

Completion Date

November 7, 2025

Last Updated

March 2, 2026

Enrollment

100

ACTUAL participants

Conditions

Hip Arthritis

Alexis Retractor in Total Hip Arthroplasty

NCT07237737

Hip OsteoarthritisHip Arthritis

View study

COMPLETED

Phenomics in Autoimmune and Inflammatory Diseases

NCT02466217

Healthy VolunteerRheumatoid Arthritis+11 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

COMPLETEDPHASE3